July 25th Options Now Available For Recursion Pharmaceuticals (RXRX)

A covered call strategy on RXRX stock, involving purchasing shares at $4.75 and selling a $5.00 strike call for 40 cents expiring July 25th, offers a potential 13.68% return if the stock is called away. However, if the contract expires worthless, the investor retains the shares and premium, yielding an 8.42% boost, with current analytics suggesting a 37% probability of this outcome; the implied volatility of the call is 97% versus a trailing twelve month volatility of 93%.

Analysis

The article details a specific covered call options strategy for Recursion Pharmaceuticals Inc. (RXRX), involving purchasing shares at the current price of $4.75 and simultaneously selling the $5.00 strike call option, expiring July 25th, for a premium of 40 cents per share. This strategy presents a potential total return of 13.68%, excluding dividends and before commissions, if RXRX stock is called away at or above $5.00 by expiration. The $5.00 strike price represents an approximate 5% premium to the current stock price, categorizing it as out-of-the-money. Current analytical data suggest a 37% probability that this call option will expire worthless. In such a scenario, the investor would retain their RXRX shares and the collected premium, resulting in an 8.42% return boost from the premium alone, which annualizes to a 61.47% YieldBoost. The implied volatility for this specific call contract is 97%, slightly elevated compared to Recursion Pharmaceuticals' actual trailing twelve-month volatility of 93%, calculated using the last 250 trading day closing values. The article underscores that while this strategy offers yield enhancement, it caps upside potential if RXRX shares experience a significant rally, making an assessment of the company's fundamentals and trading history critical.

Key Decisions for Investors

• Investors holding or considering Recursion Pharmaceuticals (RXRX) could evaluate the described covered call strategy (buying stock at $4.75, selling the July 25th $5.00 call for $0.40) to generate income, with a potential 13.68% return if the stock is called away.
• Carefully weigh the capped upside at $5.00 per share against the 8.42% upfront premium yield (the 'YieldBoost') if the option expires worthless, an outcome with a current estimated probability of 37%.
• Note the implied volatility of 97% for the call option, which is marginally higher than the stock's 93% trailing actual volatility, suggesting option sellers are compensated for slightly elevated expected price movement.
• Before executing this options strategy, conduct thorough due diligence on RXRX's underlying business fundamentals and growth outlook to ensure the capped return profile aligns with individual investment theses for the stock.